Parkinson's Disease Clinical Trial
Official title:
The Cyclical Lower-extremity Exercise for Parkinson's Trial
The purpose of this study is to gain a better understanding of how exercise training affects motor/hand function and brain function in those diagnosed with Parkinson's disease. The investigators want to study if exercise will improve hand function and improve the level of brain activity.
Current medical and surgical approaches to Parkinson's disease (PD) are expensive and
associated with a variety of side effects that may compromise the patient's quality of life.
Development of a non-drug, non-surgical therapeutic approach to improve motor function would
provide an attractive adjunct to current PD treatment approaches. Promising results from
animal exercise studies have not been translated to patients with PD.
Animal studies suggest forced-exercise produces an endogenous increase in neurotrophic
factors. An increase in these factors is believed to improve the capacity of dopamine neurons
to deliver dopamine and selectively increase dopamine levels within the dorsolateral
striatum. Models of PD provide a theoretical framework for forced-exercise and explain why
voluntary exercise is not associated with global improvements in motor function for PD
patients. Based on model predictions, decreased motor cortical activation limits PD patients'
ability to perform voluntary exercise at the relatively high rate used in animal studies that
demonstrate a therapeutic benefit. Therefore, PD patients may not be able to exercise
(voluntarily) at sufficiently high rates to trigger the endogenous release of neurotrophic
factors thought to underlie global improvements in motor functioning. A safe lower extremity
forced-exercise paradigm that augments PD patients voluntary exercise rates has been
developed for humans in an ongoing R21 project. Similar to our initial study, PD patients
completing an 8-week forced-exercise intervention exhibited nearly a 25% percent improvement
in clinical motor ratings, patients completing a voluntary exercise intervention showed no
improvement in clinical ratings. Our recent fMRI data indicate that an acute bout of
forced-exercise in PD patients produces a similar subcortical and cortical activation pattern
as is seen following administration of levodopa. Global improvements in motor function and
increased neural activity suggest forced-exercise may be altering brain function in PD
patients. The goal of this project is to determine and compare the effects of forced versus
voluntary exercise on PD motor and non-motor function and associated changes in the pattern
of neural activity.
A single-center, parallel-group, rater-blind, study in a 2:2:1 randomization is proposed. A
total of 100 mild to moderate idiopathic PD patients will be randomized to a voluntary,
forced or no-exercise control group. Exercise groups will exercise at identical aerobic
intensities, however those in the forced group will be provided mechanical assistance to
perform exercise 35% faster than their voluntary exercise rate.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 |